參考文獻(xiàn)/References:
[1] 徐建國(guó).鹽酸羥考酮的藥理學(xué)和臨床應(yīng)用[J].臨床麻醉學(xué)雜志,2014, 30(5): 511-513.
[2] Engoren M, Luther G, Fnn-Bunderer N.A comparision of fentany, sufentanil and remifentanil for fast-track cardiac anthesia [J].Anesth Analg,2001,93(4):859-864.
[3] De Schepper H U, Cremonini F, Park M I,et al.Opioids and the gut: pharmacology and current clinical experience[J].Neurogastroenterol Motil,2004,16: 383-394.
[4] Wang J,Ma H,Zhou H,et al.Effect of preoperative intravenous oxycodone administration on sufentanil consumption after retroperitoneal laparoscopic nephrectomy[J].AnaesthesiolIntensive Ther,2016,48(5):300-304.
[5] Staahl C, Christrup L L, Andersen S D,et al.A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model[J].Pain,2006,123(1/2):28-36.
[6] Parky H,Lees H,Leeo H,et al.Optimal dose of intra-venous oxycodone for attenuating hemodynamic changes after endotracheal intubation inhealthy patients: a randomized controlled trial[J].Medicine(Baltimore),2017,96(11): e6234.
[7] Charpiat B,Tod M,Darnis B,et al.Respiratory depression related to multiple drug-druginteractions precipitatedbyafluconazoleloadingdoseinapatienttreated with oxycodone[J].Eur J Clin Pharmacol,2017,73(6): 787-788.
[8] Staahl C, Dimcevski G, Andersen S D,et al.Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study[J].Scand J Gastroenterol, 2007,42(3):383-390.
[9] Gan T J, Diemunsch P, Habib A S,et al.Consensus guidelines for the management of postoperative nausea and vomiting[J].Anesth Analg, 2014, 118(1): 85-113.
[10] 劉欣鑫.婦科腔鏡手術(shù)后惡心嘔吐危險(xiǎn)因素分析[J].中國(guó)現(xiàn)代藥物應(yīng)用,2014, 8(14):90-91.
[11] 許幸,吳新民,薛張綱,等.鹽酸羥考酮注射液用于全麻患者術(shù)后鎮(zhèn)痛的有效性和安全性:前瞻性、隨機(jī)、盲法、多中心、陽(yáng)性對(duì)照臨床研究[J].中華麻醉學(xué)雜志, 2013, 33(3): 269-274.